Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels.
Gambacorti-Passerini
Carlo
C
Piazza
Rocco
R
D'Incalci
Maurizio
M
D000970:Antineoplastic Agents / Q000097:blood* / Q000627:therapeutic use*; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D016313:Genes, abl / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000097:blood* / Q000627:therapeutic use*; D011743:Pyrimidines / Q000097:blood* / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate